634P Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with atezolizumab (atezo)
Authors
S.C-H. Kao,
Martin ReckStephen Liu,
Rafał Dziadziuszko,
Maximilian Hochmair,
Florian Huemer,
Javier Castro,
Reyes Bernabé,
Sung Kim,
Dariusz Kowalski,
Zoran Andrić,
Mihaela Oancea,
M. Kaul,
H. Li,
Bettina Danner,
Michael Lee,
Barzin Nabet +15 authors
,
S. Sugawara Tip Tip